Dabigatran as good as enoxaparin for thromboembolic prophylaxis after hip replacementBMJ 2007; 335 doi: https://doi.org/10.1136/bmj.335.7620.586-a (Published 20 September 2007) Cite this as: BMJ 2007;335:586
Dabigatran etexilate is another new anticoagulant, an oral inhibitor of thrombin that could help prevent venous thromboembolism after major orthopaedic surgery. The manufacturers tested it in a head to head trial against subcutaneous enoxaparin. They found that after …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial